Anti-BCMA Neutralizing Antibody, Mouse IgG1 (recommended for neutralizing assay) |
BCA-M43 |
ACROBIOSYSTEMS |
100ug |
EUR 2354 |
|
Description: Anti-BCMA Neutralizing Antibody, is produced from a hybridoma resulting from fusion of SP2/0 myeloma and B-lymphocytes obtained from a mouse immunized with BCMA. |
Human IgG antibody Laboratories manufactures the il-22 neutralizing antibody mouse reagents distributed by Genprice. The Il-22 Neutralizing Antibody Mouse reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact mouse Antibody. Other Il-22 products are available in stock. Specificity: Il-22 Category: Neutralizing Group: Antibody Mouse
Anti-PCSK9 Neutralizing Antibody |
BPS Bioscience |
50 µg |
EUR 555 |
Description: Neutralizing recombinant human antibody (IgG1) recognizing the LDLR binding region of human PCSK9. |
Anti-LAG3, Neutralizing Antibody |
BPS Bioscience |
100 µg |
EUR 530 |
Description: Neutralizing recombinant human antibody recognizing the Lag-3 binding region. |
Anti-TIGIT Neutralizing Antibody |
BPS Bioscience |
100 µg |
EUR 565 |
Description: Human Anti-TIGIT neutralizing antibody recognizing the TIGIT binding region on immune cells. |
Goat Anti-Human Respiratory Syncytial Virus (RSV) IgG, neutralizing |
Alpha Diagnostics |
100 ul |
EUR 548.4 |
Cytomegalovirus gB Late Neutralizing Antigen (CMV-LA gB Neutralizing) Antibody |
Abbexa |
0.2 mg |
EUR 678 |
|
Monoclonal NGF/proNGF Neutralizing Antibody Antibody |
Leading Biology |
0.05mg |
EUR 633.6 |
Description: A Monoclonal antibody against Human NGF/proNGF Neutralizing. The antibodies are raised in Mouse. This antibody is applicable in E |
Antibody Mouse information
Anti-COVID-19 S-IgM Neutralizing Antibody |
E38A9973 |
EnoGene |
100ug/100ul |
EUR 225 |
Description: Available in various conjugation types. |
Anti-COVID-19 S-IgA Neutralizing Antibody |
E38A9974 |
EnoGene |
100ug/100ul |
EUR 225 |
Description: Available in various conjugation types. |
Anti-COVID-19 S-hIgG1 Neutralizing Antibody |
E38A9970 |
EnoGene |
100ug/100ul |
EUR 225 |
Description: Available in various conjugation types. |
Anti-COVID-19 S-mIgG1 Neutralizing Antibody |
E38A9971 |
EnoGene |
100ug/100ul |
EUR 225 |
Description: Available in various conjugation types. |
Anti-COVID-19 S-cIgG1 Neutralizing Antibody |
E38A9972 |
EnoGene |
100ug/100ul |
EUR 225 |
Description: Available in various conjugation types. |
Anti-NGF (Nerve Growth Factor) Neutralizing Antibody |
100436-1 |
BPS Bioscience |
50 µg |
EUR 355 |
Description: Anti-NGF Neutralizing Recombinant Human antibody. This_x000D_ antibody has not been tested for crossreactivity_x000D_ with other species. |
Anti-NGF (Nerve Growth Factor) Neutralizing Antibody |
100436-2 |
BPS Bioscience |
100 µg |
EUR 490 |
Description: Anti-NGF Neutralizing Recombinant Human antibody. This_x000D_ antibody has not been tested for crossreactivity_x000D_ with other species. |
Anti-PD-1 Neutralizing Antibody, Biotin-labeled |
71215 |
BPS Bioscience |
100 µg |
EUR 510 |
Description: Purified, recombinant, human anti-PD-1 (IgG1) antibody with C-terminal Avitag, expressed in HEK293 cells. Purified antibody was enzymatically biotinylated using Avitag™ technology. This antibody does not cross-react with mouse PD-1, but does cross-react with monkey (M. fascicularis) PD-1. It has not been tested with other species. |
Anti-2019-nCoV S-IgM Neutralizing Antibody (8A5) |
EPT006 |
ELK Biotech |
50ug |
EUR 239.4 |
|
Description: The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that SARS-CoV-2 can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. |
Anti-2019-nCoV S-IgA Neutralizing Antibody (8A5) |
EPT018 |
ELK Biotech |
50ug |
EUR 239.4 |
|
Description: The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that SARS-CoV-2 can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. |
Anti-PD-L1 Neutralizing Antibody, Biotin-labeled |
71214 |
BPS Bioscience |
100 µg |
EUR 510 |
Description: Purified, recombinant, chimeric murine/human anti-PD-L1 (IgG1) antibody with C-terminal Avi-tag, expressed in HEK293 cells. Purified antibody was enzymatically biotinylated using Avitag™ technology. This antibody reacts with human PD-L1 and cross-reacts with mouse PD-L1. It has not been tested for cross-reactivity with other species. |
Anti-2019-nCoV S-hIgG1 Neutralizing Antibody (8A5) |
EPT031 |
ELK Biotech |
50ug |
EUR 239.4 |
|
Description: The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that SARS-CoV-2 can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. |
Anti-2019-nCoV S-mIgG1 Neutralizing Antibody (8A5) |
EPT084 |
ELK Biotech |
50ug |
EUR 239.4 |
|
Description: The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that SARS-CoV-2 can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. |
Anti-2019-nCoV S-cIgG1 Neutralizing Antibody (8A5) |
EPT085 |
ELK Biotech |
50ug |
EUR 239.4 |
|
Description: The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that SARS-CoV-2 can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. |
Anti-PCSK9 Neutralizing Antibody, (IgG1) Biotin-labeled |
71216 |
BPS Bioscience |
50 µg |
EUR 530 |
Description: Purified recombinant human_x000D_anti-PCSK9 (IgG1) antibody with a C-terminal_x000D_Avi-tag, expressed in HEK293 cells. Purified_x000D_antibody was enzymatically biotinylated using_x000D_AviTag™ technology. This antibody reacts with_x000D_human PCSK9 and has not been tested for_x000D_cross-reactivity with other species. |
Anti-PCSK9 Neutralizing Antibody, (IgG4) Biotin-labeled |
71217 |
BPS Bioscience |
50 µg |
EUR 515 |
Description: Purified recombinant human_x000D_anti-PCSK9 (IgG4) antibody with a C-terminal_x000D_Avi-tag, expressed in HEK293 cells. Purified_x000D_antibody was enzymatically biotinylated using_x000D_AviTag™ technology. This protein reacts with_x000D_human PCSK9 and has not been tested for_x000D_cross-reactivity with other species. |
Spike Neutralizing Antibody (Clone G10xA1) (SARS-CoV-2) |
101326 |
BPS Bioscience |
100 µg |
EUR 600 |
Description: This monoclonal antibody recognizes the SARS-CoV-2 Spike RBD (B.1.1.529, Omicron Variant) protein and neutralizes its interaction with ACE2 [Table of Variants]. The human ACE2 receptor is found on the surface of type I and II pneumocytes, endothelial cells, and ciliated bronchial epithelial cells. ACE2 is known to mediate COVID-19 infection through direct binding of the SARS-CoV-2 Spike protein. This neutralizing antibody has been functionally tested using the Spike S1 RBD (B.1.1.529, Omicron Variant) (SARS-CoV-2):ACE2 Inhibitor Screening Colorimetric Assay Kit (BPS Bioscience #78339). |